PTR-01
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PTR-01, covering 2021-03-09 to 2022-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01) [Phase 2]